Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...